Most individuals with mutant B-Raf melanomas respond to inhibitors of oncogenic B-Raf but resistance eventually emerges. autophagy may protect UI-152-treated cells from undergoing growth inhibition. Collectively, our data implicate high rates of autophagy as a important mechanism of acquired resistance to the oncogenic B-Raf inhibitor, in support of medical studies in which combination therapy with… Continue reading Most individuals with mutant B-Raf melanomas respond to inhibitors of oncogenic